Bisoprolol Fumarate And Hydrochlorothiazide Tablet, Film Coated
FDA Label NDC 70771-1760

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Bisoprolol Fumarate And Hydrochlorothiazide (NDC 70771-1760). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Package Label.Principal Display Panel

NDC 70771-1760-3

Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP 2.5 mg/6.25 mg

30 Tablets Unit-of-Use

Rx only

2.5 mg/6.25 mg (9d6e36f0 A9e4 4b66 997a Fd5f8e4e1cf7 01)

2.5 mg/6.25 mg (9d6e36f0 A9e4 4b66 997a Fd5f8e4e1cf7 01)

NDC 70771-1761-3

Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP 5 mg/6.25 mg

30 Tablets Unit-of-Use

Rx only

5 mg/6.25 mg (9d6e36f0 A9e4 4b66 997a Fd5f8e4e1cf7 02)

5 mg/6.25 mg (9d6e36f0 A9e4 4b66 997a Fd5f8e4e1cf7 02)

NDC 70771-1762-3

Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP 10 mg/6.25 mg

30 Tablets Unit-of-Use

Rx only

10 mg/6.25 mg (9d6e36f0 A9e4 4b66 997a Fd5f8e4e1cf7 03)

10 mg/6.25 mg (9d6e36f0 A9e4 4b66 997a Fd5f8e4e1cf7 03)

* Please review the disclaimer below.